Latest news
Loading news…
Roivant Sciences
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2014 501-1000 employees For Profit
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
3
Investments
11
3 exits
Monthly Visits
Available in Pro Contacts
333
Ticker
ROIV
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ROIV
- Exchange
- NASDAQ
- IPO date
- Oct 1, 2021
- Raised at IPO
- $611M
- Valuation at IPO
- $7B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 18
- Active products
- 20
- IT spend
- $1M
Investor Activity
- Investments
- 11
- Lead investments
- 5
- Portfolio orgs
- 9
- Exits
- 3
- Exits via IPO
- 2
Company Info
- Founded
- 2014
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- Sub-organizations
- 2
- News articles
- 307
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Oct 1, 2021
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- -1.5
- Trend (90d)
- -0.9
- Last leadership hire
- May 2, 2022
- Last layoff mention
- Nov 12, 2022
Investments by Roivant Sciences
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Roivant Sciences
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Roivant Sciences
Founder and Executive Chairman
Vant Chair
Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences)
General Counsel
Chief Investment Officer & President
Chief of Staff
Chief Executive Officer
Vice President - Vant Governance & Strategy
Executive Vice President, Roivant Health
Chief Information Security Officer
Chief Development Officer
333
professional contacts at Roivant Sciences
Contact execs at Roivant Sciences →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Roivant Sciences
Loading news…
FAQs about Roivant Sciences
People who checked this page also checked these
Sectors Roivant Sciences invests & acquires in
Browse the full Acquirezy directory.